Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study

被引:33
作者
Corrie, P [1 ]
Shaw, J [1 ]
Harris, R [1 ]
机构
[1] Addenbrookes NHS Trust, Ctr Oncol, Cambridge CB2 2QQ, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7410期
关键词
D O I
10.1136/bmj.327.7410.320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:320 / 321
页数:2
相关论文
共 4 条
[1]   The ATAC (ArimidexTM, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients:: factors influencing the success of patient recruitment [J].
Baum, M .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (15) :1984-1986
[2]   Public attitudes toward participation in cancer clinical trials [J].
Comis, RL ;
Miller, JD ;
Aldigé, CR ;
Krebs, L ;
Stoval, E .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :830-835
[3]  
KMIETOWICZ Z, 2001, BRIT MED J, V325, P920
[4]  
*NAT CANC RES I, 2002, STRAT AN OV CANC RES